Summary of Product Characteristics (SmPC)
The EU product label for Tarceva can be found on the EMEA SmPC internet page.
SmPC
The EU product label for Tarceva is available in different languages.
New indication for Tarceva
Tarceva is now approved for first-line therapy of EGFR Mut+ NSCLC.
Download Center
Click to view, download or print our MoA, dosing and disease state materials.
Tarceva.com
This site is only intended for use by healthcare professionals outside of the US. If you are a US resident, please visit www.tarceva.com.